A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation

Liver Transplantation

Volumn 9, Issue 2, 2003, Pages 117-123

  Onaca, Nicholas N ^a   Levy, Marlon F ^a   Sanchez, Edmund Q ^a   Chinnakotla, Srinath ^a   Fasola, Carlos G ^a   Thomas, Mark J ^a   Weinstein, Jeffrey S ^a   Murray, Natalie G ^a   Goldstein, Robert M ^a   Klintmalm, Goran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CALCULATION; CHRONIC LIVER DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; PATIENT CODING; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 12244256131     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50027     Document Type: Article

References (11)

1. Pagliaro L. MELD: The end of Child-Pugh classification? J Hepatol 2002;36:141-142.
2. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001;7:567-580.
3. McCaughan GW, Strasser SI. To MELD or not to MELD? Hepatology 2001;34:215-216.
4. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
5. Malinchoc M, Kamath PS, Gordon ED, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
6. Sheth M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002;2:2.
7. Wiesner RH, Kim WR, Malinchoc M, Kamath PS, Kremers WK, Weinstein JS, et al. Prediction of liver transplant outcome based on pretransplant disease severity: Is there anything better than MELD? [abstract]. Hepatology 2001;34:235A.
8. Brown RS Jr, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, et al. Model for End-Stage Liver Disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002;8:278-284.
9. Casavilla FA, Rakela J, Kapur S, Irish W, McMichael J, Demetris AJ, et al. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg 1998;4:448-454.
10. Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, et al. Orthotopic liver transplantation for hepatitis C: Outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg 1999;229:824-831.
11. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: An evolution from Child to MELD. Mayo End-Stage Liver Disease. Hepatology 2001;33:473-475.